Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tenofovir disoproxil fumarate + hepatitis B vaccine + hepatitis B immune globulin
- Development stage
- Unknown
- Lead developer
- Gilead Sciences
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Administration
- Oral, Intramuscular
01
Overview
This is a combination regimen used for the prevention of mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Tenofovir disoproxil fumarate (TDF) is an antiviral medication that inhibits HBV DNA polymerase, reducing viral load in pregnant women. Hepatitis B vaccine provides active immunization to infants, stimulating their immune system to produce antibodies against HBV. Hepatitis B immune globulin (HBIG) provides immediate passive immunity by supplying preformed antibodies to neutralize the virus at birth. The combination is highly effective in preventing vertical transmission of HBV when administered according to recommended protocols[6][7][8].
- Other names
- TDF + HBV vaccine + HBIGtenofovir disoproxil fumarate and hepatitis B vaccine and hepatitis B immune globulin
02
Targets
HBsAg (Hepatitis B surface antigen)HBV Pol (Hepatitis B virus polymerase)
Beyond the preview
Go deeper on tenofovir disoproxil fumarate + hepatitis B vaccine + hepatitis B immune globulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tenofovir disoproxil fumarate + hepatitis B vaccine + hepatitis B immune globulin.